The abstract is read at the publisher; the summary is JClub's.
Integrated clinical, biochemical, and molecular testing in 10 Egyptian patients with spastic paraplegia identified pathogenic or likely pathogenic variants in nine disease genes, including seven novel variants.
- Why it matters: Inborn errors of metabolism are rare and often missed causes of spastic paraplegia, and some are potentially treatable despite mimicking pure or complex hereditary spastic paraplegia.
- What they did: The study evaluated 10 patients using clinical assessment, biochemical profiling, and molecular diagnostics, finding eight homozygous and two compound heterozygous genotypes across ages 1.9–17 years.
- The result: Abnormal metabolic profiles were reported in 5/10 (50%), and early molecular diagnosis enabled precise disease identification and targeted therapy for these neurometabolic mimics.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.